BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of celastrol derivatives as anticancer agents. 2015

Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
School of Pharmacy, Anhui Medical University, Hefei, 230032, PR China.

A series of celastrol derivatives as potential telomerase inhibitors were designed and synthesized. The bioassays demonstrated that title compounds displayed potent anticancer activities against SGC-7901, SMMC-7721, MGC-803 and HepG-2 cell lines, among them, compounds 3c and 3d which containing hydrophilicity moieties exhibited high anti-proliferative activities (IC50 = 0.10-1.22 μM). The preliminary mechanism of antitumor action indicated that title compound 3c could induce significant SMMC-7721 cells apoptosis. A modified TRAP assay showed that compounds 3c and 3d displayed the most potent inhibitory activity with IC50 values at 0.11 and 0.34 μM, respectively. And there was a good correlation between telomerase inhibition and anti-proliferative inhibition of SMMC-7721 cells. Moreover, molecular docking indicated that the active compound 3c was nicely bound into the telomerase hTERT active site, hydrophobic, van der Waals and two hydrogen bond interactions with conserved residues ASP 628 and TYR 949 were found.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design and Synthesis of Novel Celastrol Derivatives as Potential Anticancer Agents against Gastric Cancer Cells.
May 2022, Journal of natural products,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents.
July 2014, Molecules (Basel, Switzerland),
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents.
September 2019, Molecules (Basel, Switzerland),
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
October 2017, Bioorganic & medicinal chemistry letters,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents.
February 2021, Molecules (Basel, Switzerland),
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
January 2015, European journal of medicinal chemistry,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents.
May 2019, Bioorganic & medicinal chemistry letters,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
February 2018, Bioorganic & medicinal chemistry letters,
Wen-Jian Tang, and Jing Wang, and Xu Tong, and Jing-Bo Shi, and Xin-Hua Liu, and Jun Li
Design, synthesis and evaluation of novel levoglucosenone derivatives as promising anticancer agents.
July 2020, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!